ANVS -
Annovis Bio, Inc.
1.7
-0.50 (-22.73%)
As of October 10, 2025 4:00 pm EDT
Quote Detail
| Last | 1.70 |
|---|---|
| Change | -0.50 |
| Change % | -22.73 |
| Bid | 1.68 X 400 |
| Ask | 1.73 X 100 |
| Volume | 7.81 M |
| Shares | 19.49 M |
| Market Cap | 42.87 M |
| Open | 1.61 |
|---|---|
| High | 1.80 |
| Low | 1.60 |
| Prev Close | 2.20 |
| 52 Wk High | 10.54 |
| 52 Wk Low | 1.11 |
| EPS | -2.0359 |
| P/E | n.a. |
| Div Yield | n.a. |
Market Headlines
BioMedNewsBreaks -- Annovis Bio Inc. (NYSE: ANVS) Appoints Mark Guerin as Chief Financial Officer
Sep 25, 2025 (Investor Brand Network via COMTEX News Network) -- Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company developing therapies for neurodegenerative diseases, announced...
BioMedNewsBreaks -- Annovis Bio Inc. (NYSE: ANVS) Advances Phase 3 Alzheimer's Trial, Strengthens IP Portfolio, Reports Q2 2025 Results
Aug 13, 2025 (Investor Brand Network via COMTEX News Network) -- Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company developing therapies for neurodegenerative diseases, announced...
